Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$1.28 - $1.9 $1,344 - $1,995
1,050 Added 8.87%
12,882 $16,000
Q1 2024

May 13, 2024

SELL
$1.35 - $2.27 $1,350 - $2,270
-1,000 Reduced 7.79%
11,832 $19,000
Q4 2023

Feb 12, 2024

SELL
$1.27 - $2.06 $7,366 - $11,948
-5,800 Reduced 31.13%
12,832 $22,000
Q3 2023

Nov 13, 2023

BUY
$1.8 - $3.61 $2,340 - $4,693
1,300 Added 7.5%
18,632 $39,000
Q2 2023

Aug 14, 2023

SELL
$1.14 - $1.63 $341 - $488
-300 Reduced 1.7%
17,332 $28,000
Q4 2022

Feb 13, 2023

BUY
$1.6 - $2.37 $5,067 - $7,505
3,167 Added 21.89%
17,632 $32,000
Q3 2022

Nov 14, 2022

BUY
$2.04 - $4.32 $2,040 - $4,320
1,000 Added 7.43%
14,465 $30,000
Q2 2022

Aug 15, 2022

BUY
$3.02 - $4.56 $1,208 - $1,823
400 Added 3.06%
13,465 $54,000
Q1 2022

May 13, 2022

BUY
$3.92 - $7.48 $2,038 - $3,889
520 Added 4.15%
13,065 $58,000
Q4 2021

Feb 14, 2022

SELL
$6.7 - $11.38 $150,080 - $254,912
-22,400 Reduced 64.1%
12,545 $90,000
Q3 2021

Nov 15, 2021

BUY
$10.11 - $17.56 $208,872 - $362,789
20,660 Added 144.63%
34,945 $376,000
Q2 2021

Aug 13, 2021

SELL
$14.9 - $20.82 $16,986 - $23,734
-1,140 Reduced 7.39%
14,285 $248,000
Q1 2021

May 14, 2021

BUY
$12.57 - $21.22 $23,820 - $40,211
1,895 Added 14.01%
15,425 $327,000
Q4 2020

Feb 12, 2021

SELL
$8.73 - $14.56 $7,813 - $13,031
-895 Reduced 6.2%
13,530 $179,000
Q3 2020

Nov 16, 2020

BUY
$8.56 - $11.6 $33,170 - $44,950
3,875 Added 36.73%
14,425 $127,000
Q2 2020

Aug 14, 2020

BUY
$6.63 - $12.85 $69,946 - $135,567
10,550 New
10,550 $105,000
Q2 2019

Aug 14, 2019

SELL
$4.53 - $7.0 $76,896 - $118,825
-16,975 Closed
0 $0
Q3 2018

Nov 13, 2018

SELL
$2.85 - $3.19 $2,850 - $3,190
-1,000 Reduced 5.56%
16,975 $50,000
Q2 2018

Aug 14, 2018

BUY
$3.04 - $3.93 $19,152 - $24,759
6,300 Added 53.96%
17,975 $54,000
Q1 2018

May 11, 2018

BUY
$2.96 - $4.0 $34,558 - $46,700
11,675 New
11,675 $36,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $49.4M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.